Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Amarin Corp Plc

Amarin Corp Plc (AMRN)

Market is closed
News
Analyst Roundtable: Any Surprises in Amarin Corporation plc (ADR) (AMRN)'s Fourth Quarter?

Analyst Roundtable: Any Surprises in Amarin Corporation plc (ADR) (AMRN)'s Fourth Quarter?

Motley Fool health care analyst Max Macaluso and Fool contributor Brian Orelli sat down to discuss Amarin Corporation plc (ADR) (NASDAQ:AMRN) , a biotech that recently launched its first drug, Vascepa...

Keep Reading →

March 6th, 2013 - News

3 Bio-Pharmaceuticals You Can't Ignore: Arena Pharmaceuticals, Inc. (ARNA), VIVUS Inc. (VVUS)

3 Bio-Pharmaceuticals You Can't Ignore: Arena Pharmaceuticals, Inc. (ARNA), VIVUS Inc. (VVUS)

The last year has been a stellar one for the biotechnology industry.

Keep Reading →

February 26th, 2013 - News

A Buyout In Amarin Corporation plc (ADR) (AMRN) Is Imminent!

A Buyout In Amarin Corporation plc (ADR) (AMRN) Is Imminent!

All throughout Wall Street we keep hearing about Amarin Corporation plc (ADR) (NASDAQ:AMRN) being bought out by some type of Big Pharma company in the future.  It's all rumors circling around, but it...

Keep Reading →

February 22nd, 2013 - News

3 Horrendous Health-Care Stocks This Week: Accuray Incorporated (ARAY), Keryx Biopharmaceuticals (KERX)

3 Horrendous Health-Care Stocks This Week: Accuray Incorporated (ARAY), Keryx Biopharmaceuticals (KERX)

OraSure Technologies, Inc. (NASDAQ:OSUR) announced its fourth-quarter results after the market closed on Wednesday. The oral fluid diagnostics maker beat analyst expectations by $0.03 per share.

Keep Reading →

February 9th, 2013 - News

Here’s What Tocqueville Asset Management Has Been Buying and Selling: Sarepta Therapeutics Inc (SRPT), Amarin Corporation plc (AMRN)

Here’s What Tocqueville Asset Management Has Been Buying and Selling: Sarepta Therapeutics Inc (SRPT), Amarin Corporation plc (AMRN)

Today, let's look at Tocqueville Asset Management, which is a portfolio manager with a contrarian bent, believing that "the best investment results over time are achieved outside the mainstream consensus...

Keep Reading →

February 6th, 2013 - Hedge Funds

Insider Monkey Quarterly Strategy
+336.2% Insider Monkey Quarterly Strategy
+144.8% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through November 14th, 2024)